Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic mir-34a in gynostemma pentaphylla (thunb.) makino treated mice

HIGHLIGHTS

• who: Ning Jia from the University, Jing , Rd, Jinan, China have published the research: Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic miR-34a in Gynostemma pentaphylla (Thunb.) Makino treated mice, in the Journal: (JOURNAL)
• what: The authors evaluated the role of GP in the treatment of NAFLD in_vivo and found that GP was effective in reducing the hepatic steatosis and protecting hepatocytes, likely by modulation of gut microbiota and suppression of miR-34a. In this paper the effect of GP on NAFLD was evaluated holistically.
•  

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.